NASDAQ:LFWD Lifeward Q2 2026 Earnings Results & Report $6.12 +0.03 (+0.41%) As of 11:58 AM Eastern This is a fair market value price provided by Massive. Learn more. Lifeward missed analyst earnings expectations but beat on revenue in its Q2 2026 results, released August 15, 2026. The company reported EPS of -$1.46 versus the -$1.39 consensus estimate, while revenue of $6.62 million topped the $6.53 million estimate by $0.09 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 15, 2026TimeBefore Market OpensConference Call DateAugust 14, 2026Conference Call9:30 AM ET Lifeward EPS ResultsActual EPS-$1.46Consensus EPS -$1.39Beat/MissMissed by -$0.07One Year Ago EPSN/AEPS Beat Rate0 of last 8 quartersLifeward Revenue ResultsActual Revenue$6.62 millionExpected Revenue$6.53 millionBeat/MissBeat by +$92.00 thousandYoY Revenue GrowthN/AUpcoming EarningsLifeward's Q3 2026 earnings is estimated for Friday, November 13, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Lifeward Q2 2026 Earnings FAQ Did Lifeward beat earnings estimates for Q2 2026? Lifeward (NASDAQ:LFWD) reported earnings of -$1.46 per share for Q2 2026, missing the consensus estimate of -$1.39. The report was announced on Saturday, August 15, 2026. What was Lifeward's revenue for Q2 2026? Lifeward reported revenue of $6.62 million for Q2 2026, against a consensus estimate of $6.53 million. When is Lifeward's next earnings date? Lifeward's next earnings date is estimated for Friday, November 13, 2026. MarketBeat tracks confirmed and estimated earnings dates for Lifeward on the company's earnings history page. Lifeward Earnings HeadlinesLifeward's ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study4 hours ago | globenewswire.comLifeward (LFWD) Stock Forecast & Price TargetOctober 10, 2026 | investing.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.October 14 at 1:00 AM | Weiss Ratings (Ad)Lifeward Announces Interim CFO Leadership Transition PhaseOctober 1, 2026 | tipranks.comLifeward Sets Timeline for 2026 Shareholder MeetingSeptember 15, 2026 | tipranks.comLifeward Study Shows ReWalk Exoskeleton Improves Daily Activities, Satisfaction And PainSeptember 15, 2026 | rttnews.comSee More Lifeward Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Lifeward? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifeward and other key companies, straight to your email. Email Address About LifewardLifeward (NASDAQ:LFWD), formerly known as ReWalk Robotics Ltd., is a medical technology company focused on developing wearable robotic systems that support mobility and rehabilitation. Its technologies are designed primarily for people with lower-limb disabilities, including individuals with spinal cord injury, as well as patients recovering from neurological conditions such as stroke. The company’s principal products include the ReWalk Personal Exoskeleton, a wearable robotic device intended to help eligible individuals stand, walk and perform daily activities, and the ReStore Exo-Suit, a soft, lightweight robotic system designed for use in rehabilitation centers to assist gait training. Lifeward’s products combine motorized support, sensors and software to help users practice or achieve more natural walking movements. Originally established as ReWalk Robotics, the company markets its systems through medical and rehabilitation channels in the United States, Europe and other international markets, subject to applicable regulatory clearances. The company adopted the Lifeward name as part of a broader effort to represent its focus on mobility and physical rehabilitation technologies.View Lifeward ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Albertsons Is Betting on a Turnaround—But Will It Pay Off?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American BusinessTax Credit Turmoil: Why Enphase and SolarEdge Face a Tough RoadSurgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
